Case Reports

SCC supports the practice of evidence-based cannabinoid medicine. This collection of research studies exists to guide clinical decision making. All included articles have been vetted by Board members to ensure that only rigorous, unbiased, and non-commercialized studies are included.


Entry ID5

Medical ConditionPsychiatric disorders


Mixed mood disorder
Medical Condition
Psychiatric disorders
Generalized anxiety, panic attacks, seasonal depression, suicidal thinking, insomnia
Psychiatric Disorders
52 y/o male with mixed mood disorder on muliple medications with incomplete improvement, responded well to CBD rich strains of cannbis.
Patient information
Brief history and target symptomatology
52 year old male with greater than 30 year history of mood disorder. Past medications included multiple SSRIs, SNRIs, mood stabilizers, benzodiazepines and hypnotics. Cannabis had been quite effective at reducing need for antidepressants for 5 years, however anxiety, panic and insomnia had remained intermittently problematic, and medication side effects were significant. Switched to high cbd strain (Cannatonic) as a bedtime unheated dose with near complete resolution of insomnia and generalized anxiety. Using L-theanine during the day for occasional panick attacks.
Previous and current conventional therapies
Numerous SSRIs, SNRIs, benzodiazepines and zolpidem, talk therapy, numerous traditional herbs, meditation and exercise.
Clinical response to Cannabis
Used as an evening unheated oral preparation, response has been remarkable and improving. CBD dose is estimated to be about 100mg.
Additional Comments
Patient has resumed aerobic exercise and is working to restore previous social activities.
Usual method of Cannabis administration
Cannabis strain (if known)
Cannatonic, AC/DC
Frequency of Usage: Time Per Day
Frequency of Usage: Days per Week